Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA
Filed in archive News , Treatment on April 17, 2007
Mylan Pharmaceuticals' generic Glipizide and Metformin hydrochloride Tablets has recently been granted final approval by the US FDA.
Both oral blood glucose lowering drugs, glipizide and metformin are used for the treatment of type 2 diabetes when diet alone is not sufficient, but with different mechanisms of action: glipizide by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently while metformin hydrochloride, by decreasing sugar production and absorption and helping your body respond better to its own insulin.
Glipizide's popular brand is Glucotrol® by Pfizer while metformin hydrochloride is known as the brand Glucophage®, a product of Bristol-Myers Squibb.
Additionally, these two blood glucose-lowering ingredients are found in one product: Bristol-Myers Squibb's Metaglip™ Tablets.
Thanks to Mylan Pharmaceuticals, Metaglip™ now has a USFDA-approved generic counterpart.
Source: Mylan Laboratories, Inc.

Permalink: Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA
Tags: generic drugs metformin glipizide type 2 diabetes
Vote for Mylan Pharma's Generic Glipizide and Metformin Hydrochloride Tablets, Approved by the USFDA:
|
Rating: 8.33 out of 3 vote(s) cast.
|
Response from:
Trusted.MD Network
The first generic versions of Risperdal (risperidone) tablets has recently been approved by the FDA.
Response from:
Trusted.MD Network
| RSS | |
|
| |
| Yahoo! |
|
| Bloglines |
|
| Follow us on Twitter! |
Most Popular
Best of
Blogs, Blogging & Blogosphere
Challenges
Developments
Diabetics' Device
Did you know
Diet
Education
Exercise
Family Matters
Friends
Fun
Information
Information about
Inspiration
Interviews
Lifestyle
Misc
News
Notable


